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Background: Several methods exist to asses 
and control physical intensity levels of subjects 
engaged in physical activities programs, accel-
erometry is a method that could be easily used 
in the field. The purposes were: to calibrate 
Actigraph in middle-aged to old obese/over-
weight and DM2 adult patients; and to deter-
mine the threshold counts for sedentary, light, 
moderate, and vigorous physical activity (PA). 
Methods: Sample comprise 26 participants 
(62.6 ± 6.5 years of age) of both gender. Counts 
and VO2 were simultaneously assessed during: 
resting, seating, standing, walking at 2.5 
km·h–1, 5 km·h–1, and 6 km·h–1. A hierarchical 
linear model was used to derive a regression 
equation between MET and counts. Receiver 
operating characteristics (ROC) analysis was 
used to define thresholds for PA levels. Results: 
The regression equation was: MET = 
1.388400490262 + 0.001312683420044 
(counts·min–1), r = .867. The threshold counts 
for sedentary-light, light-moderate and moder-
ate-vigorous PA were: 200, 1240, 2400 
counts·min–1 respectively. Conclusion: The 
Actigraph is a valid and useful device for the 
assessment of the amount of time spent in each 
PA intensity levels in obese/overweight and 
DM2 middle-aged to old adult patients.
Keywords: intervention study, exercise 
prescription, motion sensors
One of the most important factors in preventing and 
treating obesity as well as some of the morbidities asso-
ciated with it, namely type 2 diabetes mellitus (DM2), is 
physical activity1 (PA). Regular PA is a fundamental 
part of lifestyle behavior in treating DM2,2 and on the 
primary prevention of this disease.1,3,4 There are several 
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benefits of regular PA in individuals with DM2: it 
reduces the risk of cardiovascular disease,5 glycated 
hemoglobin A1c,2 blood pressure,3,6 and total abdomi-
nal fat;7 it also improves insulin sensitivity,7 glycemic 
control,6,8 and increases the muscle mass.9 Regular 
moderate-intensity PA can be used to improve meta-
bolic risk variables such as insulin and leptin in over-
weight/obese postmenopausal women.10
Since PA improves energy expenditure which can 
cause a negative energetic imbalance, it should be con-
sidered as one of the most important factors in weight 
control. As a consequence, PA is important for the pre-
vention of comorbidities associated with overweight 
and obesity, namely DM2.
In this context, it is important to control the exer-
cise and PA intensity of obese and diabetic individuals 
that are engaged in PA programs. Among several instru-
ments available for that purpose, accelerometers have 
been used as objective measurement tools, that allow 
the quantification of the amount of time spent in light 
(<3 metabolic equivalents, or METs), moderate (3–5.99 
METs), and vigorous (≥6 METs) PA. This way, acceler-
ometers should be calibrated to have population specific 
energy expenditure equations.11,12 This is due to the fact 
that PA habits change with age. On one hand, children 
are characterized as having short bouts of relatively 
intense PA interspersed with frequent rest periods.13,14 
On the other hand, adults have continuous periods of 
PA, mostly in ambulatory activities. In older adults, the 
main mode of PA is walking and other ambulatory 
activities, and they perform significantly fewer minutes 
of moderate to vigorous PA than young adults.15 The 
measurement of lifestyle activities with accelerometers 
is somewhat limited. Nevertheless they measure loco-
motor activities quite well,16 which makes them quite 
suitable to measure PA in an old adult population.
There are some previous calibration studies per-
formed on adults, although they were done with young 
and healthy adults.16–19 As far as we know, no calibra-
tion studies with middle-aged to old obese/overweight 
and DM2 adult patients were performed.
For the same physical activity effort obese/over-
weight subjects spend more energy than normal weight 
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years of age. The sample for validation (sample 2) com-
prised 12 middle-aged to old adults of both genders, 
with 62.2 ± 6 years of age. All participants have been 
taking oral antidiabetic medication (metformin), but no 
insulin, and they did not have any chronic diabetic com-
plications. There is the assumption that metformin could 
influence the VO2, however, the available research21–24 
is not conclusive about this issue. All participants were 
white, and their characteristics are shown, by sample, in 
Table 1.
All the selected participants had to sign a docu-
ment, to give permission to proceed with the evaluations 
and the study was approved by the ethical committee of 
the local health authority.
Instrumentation
Oxygen consumption (VO2) and heart rate were mea-
sured using a stationary breath-by-breath metabolic unit 
(Cortex, Model MetaLyzer 3B, Leipzig, Germany), 
which was calibrated with standard gases before each 
test was performed. The unit includes a heart rate trans-
mitter (Polar Electro Oy, Kempele, Finland).
Each participant wore 2 Actigraph (The ActiGraph, 
LLC., Pensacola, FL, USA), formerly the Manufactur-
ing Technology Incorporated Actigraph, and the Com-
puter Science Applications accelerometer, over their 
right hip, to prevent any malfunction of the PA monitor, 
or other mishap. The Actigraphs were the same for all 
participants. Both units were previously calibrated 
according to the manufacturer’s parameters. The varia-
tion between the results obtained by both units were 
analyzed by means of intraclass correlation, thus result-
subjects. In fact, body weight is a major factor in rest 
metabolic rate and total daily energy expenditure. In 
addition, it seems that DM2 patients of 61 years of age 
have lower peak VO2 than nondiabetic patients.20 For 
these reasons it is important to have specific counts cut-
off values for this specific group of subjects.
The purposes of this study were to calibrate Acti-
graph (The ActiGraph, LLC., Pensacola, FL, USA), for-
merly the Manufacturing Technology Incorporated 
Actigraph, and the Computer Science Applications 
accelerometer, in middle-aged to old obese/overweight 
and DM2 adult patients, and to determine the thresholds 
counts for sedentary, light, moderate, and vigorous 
levels of PA in ambulatory activities.
Methods
Study Participants
The participants were recruited from a population of 
patients with DM2, enrolled in a PA program, designed 
for secondary prevention and as a complementary treat-
ment of DM2. After their assistant physician found no 
counter-indication for the practice of physical exercise, 
the patients were invited to participate in the PA pro-
gram. Only the subjects with no diabetic chronic com-
plications, who only take oral antidiabetic medication, 
with diagnosed diabetes for over 2 years and who were 
obese or overweight, were selected for the current 
study.
The sample for calibration (sample 1) comprised 14 
middle-aged to old adults of both genders, with 63 ± 7 






Female (%) 50 66.7
Mean age (y) 63 ± 7 62.2 ± 6
Education level (%)
 Secondary education 57.2 41.7
 Primary school 42.8 58.3
Height
 Male 168.07 ± 5.18 162.63 ± 3.54
 Female 151.49 ± 8.54 155.10 ± 7.99
Weight
 Male 80.32 ± 7.21 75.90 ± 16.03
 Female 77.05 ± 21.03 72.19 ± 17.58
Body mass index 31.00 ± 5.17 29.33 ± 4.85
Obese (%) 57.1 41.7
Overweight (%) 42.9 58.3
HbA1c (%) 7.20 ± 1.8 7.34 ± 1.81
Fasting glucose (mg/dL) 145.43 ± 34.30 148.87 ± 35.63
Insulin (uUI/mL) 9.60 ± 4.41 9.25 ± 4.47
IR (HOMA-IR) 1.59 ± 0.71 1.53 ± 0.72
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actual value of MET, and the 95% limits of absolute 
agreement were calculated as described in Atkinson and 
Nevill.28
The concordance correlation coefficient c,29 which 
evaluates the degree to which pairs of observations fall 
on the 45° line through the origin, was computed 
between the predicted and the actual values.
Threshold for Ambulatory Physical Activity Intensity 
Levels. Actigraph counts corresponding to the MET 
cut-offs for sedentary, light, moderate, and vigorous 
levels of PA, were calculated from the derived 
equation.
Receiver operating characteristics (ROC) analysis 
was then applied. The sensitivity [true positives/(true 
positives + false negatives)] and specificity [true nega-
tives/(true negatives + false positives)] of the thresholds 
for counts were calculated. The cut-offs counts were 
selected having in consideration the highest values of 
sensitivity and specificity that had simultaneously the 
largest area under the curve. This was done using data 
provided by both samples.
Results
Study Subjects Characteristics
In sample 1, the body max index (BMI) was 28.4 ± 2.1 
and 33.1 ± 6.2, respectively, for male and female sub-
jects. The average waist-to-hip ratio was 0.97 ± 0.1 for 
male and 0.96 ± 0.1 for female. Rest metabolic rate 
(RMR) was 3.48 ± 1.15 and 2.37 ± 0.30 mL·kg−1·min−1 
for men and women, respectively. In sample 2, the BMI 
for males was identical to sample 1 (28.5 ± 4.9), but 
slightly lower for females (29.7 ± 5.4). The average 
waist-to-hip ratio for male was also identical to the 
sample 1 (0.95 ± 0.03), and again slightly lower for 
women (0.88 ± 0.02). Rest metabolic rate was 3.15 ± 
0.95 and 2.32 ± 0.55 mL·kg−1·min−1 for men and women, 
respectively.
The differences between samples (male and female 
combined) in height, weight and BMI were not statisti-
cally significant, apart from waist-to-hip ratio (t(22) = 
2,97, P = .007). There were no significant differences in 
RMR between samples. Considering the joined samples, 
half of the participants were obese (n = 13) and the other 
half were overweight (n = 13).
The performance data obtained during the experi-
mental protocol are presented in Table 2. In both sam-
ples, the performance indicators improved over ambula-
tory PA intensities. There were no significant differences 
between samples in any of the PA intensities in any vari-
able. The only exception was in counts in standing 
activity, where sample 1 had more counts. The chosen 
activities provided a wide range in VO2 (3−23.9 
ml·kg−1·min−1) with a corresponding wide range in Acti-
graph counts (2.3−5389.5 counts·min−1).
ing in a high value (r = .99). Only the data of the same 
unit were used for the subsequent analyzes. Activity 
counts were stored in 1-min time intervals.
Study Design
Since the majority of the activities proposed in the PA 
program involving the recruited participants had walk-
ing as the main physical activity, and since walking is 
the most frequent PA in this age group,25 it was decided 
to perform a laboratory protocol which included walk-
ing using a treadmill.
All participants were asked to present themselves at 
the laboratory 3 hours after their last meal. To evaluate 
VO2 and Actigraph counts simultaneously, each partici-
pant did the following physical activities in sequence: 
resting, seating, standing, walking at 2.5 km·h−1, 5 
km·h−1, and 6 km·h−1. These activities were intended to 
cover rest, light, moderate, and vigorous PA intensities.
Rest VO2 was collected for 15 min with the partici-
pants in a lying position, in a silent and dimly lighted 
room. Participants were not allowed to sleep. Minutes 6 
to 15 were used for data analysis. For all activities other 
than resting, VO2, heart rate and Actigraph counts were 
collected during 6 min, and the mean value of the last 3 
min was used for data analysis. During this period, the 
participants were considered to be at a steady-state 
energy expenditure since it was a submaximal physical 
effort.26
All participants attended, at least, 1 visit to the lab-
oratory, before the visit to collect VO2, heart rate, and 
accelerometry data. In these visits, weight, height, waist 
and hip circumferences, as well as skinfolds (subscapu-
lar, triceps, suprailium, midthigh and medial-calf) were 
measured. Another purpose of these visits was to let the 
participants to walk on the treadmill to get used to it. 
The same protocol was applied to both samples.
Statistical Analysis
A hierarchical linear model was used to analyze the 
relationship between Actigraph counts and MET, over 
the walking activity intensities. This procedure allows 
the accounting for the dependence among repeated mea-
sures in the same subject. Restricted maximum likeli-
hood estimates of random effects and maximum likeli-
hood estimates of fixed effects were obtained using 
SPSS 15.27 Coefficients associated with quadratic and 
cubic trends in third polynomial model were not found 
to be significantly different from zero. The contribution 
of body mass index (BMI), waist-to-hip ratio, sum of 
skinfolds and gender was tested. None of them was 
found to contribute significantly to the fit of the model. 
Thus, only results from the unadjusted hierarchical 
linear model are reported.
Analysis for Inner Validation. The bias, which is the 
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value lie between –3.97 and 3.70 MET, and in sample 1 
between –2.40 and 2.82. In both cases it is an enough 
narrow interval for the model to be of practical use.
The value of the concordance correlation coeffi-
cient between predicted and actual values of joined 
samples was high (c = 0.80).
Thresholds for Sedentary, Light, 
Moderate, and Vigorous Intensity of 
Ambulatory Physical Activity
The thresholds corresponding to sedentary (<1.5 MET), 
light (1.5 to 3 MET), moderate (3–6 MET), and vigor-
ous (6–9 MET) levels of ambulatory PA, the associated 
sensitivity and specificity, and the area under the curve, 
determined by binary classification (sedentary-light, 
light-moderate, moderate-vigorous) are presented in 
Table 3. The resulting ROC curve characterizes the per-
formance of a binary classification by describing the 
trade-off between sensitivity and specificity, over an 
entire range of possible thresholds. Several values 
between 1 and 300 counts·min−1, were tested in the 
threshold for sedentary-light. The counts·min−1 values 
of ±300, ±1300, and ±1000 given by the inverted MET 
equation were respectively tested in the thresholds for 
light-moderate, and moderate-vigorous.
The ROC analysis indicates excellent results for 
threshold counts for sedentary-light, light-moderate and 
moderate-vigorous with the area under the curve higher 
than 0.90. The sensitivity was 100% for all thresholds, 
except for sedentary-light. Specificity was lower for 
moderate-vigorous (69.74%) than in the other thresh-
olds (76.81% to 94%).
Discussion
The purposes of this study were to calibrate Actigraph 
in obese/overweight and DM2 middle-aged to old adult 
patients, as well as to determine the thresholds of Acti-
graph counts for sedentary, light, moderate, and vigor-
ous levels of ambulatory PA.
Our data revealed that the Actigraph counts were 
highly correlated with MET scores, in fact, Actigraph 
counts accounted for 75.2% of variation in observed 
MET scores. The equation for MET estimation from 
counts, allows the use of the Compendium of Physical 
Activities to estimate energy expenditure over a wide 
range of ambulatory activities.30 The contribution of 
BMI, waist-to-hip ratio, sum of skinfolds and gender 
were found to be non significant to the fit of the model. 
Conversely, Freedson et al18 included BMI in the equa-
tion to predict energy expenditure in young male (24.4 
± 4.2 years of age) and female (22.9 ± 3.8 years of age) 
adults.
It was found that 1 MET was slightly lower (3.48 ± 
1.15 and 2.37 ± 0.30 mL·kg−1·min−1 for men and women, 
respectively) than 3.5 mL·kg−1·min−1, adopted for the 
adult population, so the participant’s actual resting 
Prediction Equation for MET Scores from 
Counts
The data of all ambulatory PA intensities and the data of 
resting were used to derive the equation for MET scores. 
This procedure allows the anchoring of the intercept 
term of the equation on the low end of MET scores. 
Figure 1 shows the regression lines for MET scores 
versus Actigraph counts for each subject (thin lines) and 
the overall regression line (thick line). Equation 1 esti-
mates MET scores using counts. METs were calculated 
as energy expenditure for each PA level divided by the 
subject measured rest metabolic rate.
MET = 1.388400490262 + 0.001312683420044 
(counts·min−1) [1]
The measured MET scores were regressed against esti-
mated MET scores, an r = .867 was obtained, so 75.2% 
of the variation in measured MET scores in the sample 
was explained by the counts.
Analysis for Inner Validation
The regression equation derived in sample 1 for predic-
tion MET scores was used to estimate MET scores in 
sample 2. The predicted MET scores was significantly 
correlated with measured MET scores (r = .781, P < 
.01).
Agreement
The bias for sample 1 and sample 2 was 0.21 ± 1.33 and 
–0.13 ± 1.95, respectively. So, for a new individual from 
the studied population, it would be expected (an approx-
imate 95% probability) that the difference between the 
actual and predicted value should lie within the limits of 
agreement. Therefore, in sample 2, it would be expected 
that the differences between the actual and predicted 
Figure 1 — Regression line for MET score versus acceler-
ometer (Actigraph) counts (random regression line for each 
individual and overall regression line).
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= .85 to 0.89). In the equation developed in old adult 
patients with coronary artery disease, Ekelund et al35 
found a validation of r2 = .72. Thus, the equation 
obtained in the current study has a comparable valida-
tion coefficient with the previous studies. The results of 
inner validation also show that the equation has good 
indicators, which support its practical use. The limits of 
agreement were relatively narrow and the concordance 
correlation coefficient was high.
A criticism that can be made to this study is the fact 
that it used a laboratory protocol (walking on a tread-
mill) instead of free-living activities. However, the mode 
of PA of adults, and especially old adults, is predomi-
nantly walking.25,38 Thus, on the laboratory treadmill, 
the subjects performed the most frequent mode of PA in 
this population group.
The current study could benefit if it had embraced a 
larger sample, but there were some difficulties to recruit 
more voluntaries. The sample subjects were recruited 
from a PA program designed for secondary prevention 
and complementary treatment of DM2. All the obese/
overweight subjects that were enrolled in the program 
participated in the study.
Not all the validation/calibration studies calculated 
cut-off counts for PA intensity levels. Moreover, none of 
the studies derived cut-off counts for sedentary and for 
light PA. Based on the results of ROC analysis, namely 
the area under the curve and the values of sensitivity and 
specificity, it can be stated that the found cut-off values 
would be effective in characterizing PA levels. The cut-
off counts value between sedentary and light PA was 
200 counts, which represent the activity with minimal 
body movement in a sitting or standing position. For 
Actigraph activity monitor in children (6 to 16 years 
old) Puyau et al39 found a higher value (800 counts), and 
Treuth et al40 observed a cut-off count value of 100 in 
adolescent girls.
Between light and moderate PA there was a cut-off 
of 1240 counts. In other studies,17–19 the values vary 
between 1952 and 2260. These values are slightly higher 
than the value found in the current study. However, the 
samples of those studies were, as previously explained, 
young and healthy adults. The cut-off count value 
between moderate and vigorous PA levels were 2400 
counts, again a value below the cut-off values found in 
the literature,17–19 which vary between 5725 and 6893.4 
counts. In the sample of the current study the resulted 
cut-off points were nearly 1000 Actigraph counts less 
than those in the literature. These differences could be 
values were used to estimate MET levels. This proce-
dure reduced the bias in the estimated energy cost of the 
physical activities measured in these middle-age to old 
adults, and are consonant with the fact that RMR decline 
with age.31,32
The original part of this study is that there is not, as 
far as we know, any study that has tried to derive an 
equation to MET scores through Actigraph counts, for 
obese/overweight and DM2 middle-aged to old adult 
patients. There are several equations to estimate energy 
expenditure through accelerometry counts for adults, 
but all of them are for young and healthy adults.18,33,34 
To our knowledge, there is only 1 study done with a 
sample of older subjects which suffer from coronary 
artery disease.35 In this study Actigraph was validated in 
a sample of 34 old adults (≥70 years) coronary artery 
disease patients. They also used the walking activity in 
the treadmill at different speeds (3.2, 4.8 and 6.4 km·h−1), 
almost the same walking speed that was used in the cur-
rent study.
The use of generalized equations in old adults is not 
overall recommended, since there are differences in 
muscle mass, gait, and other functional aspects,36 and 
because all of the known equations reporting MET used 
the value of 1 MET = 3.5 kcal·kg−1·min−1 (which is an 
estimate of resting energy expenditure) in their mea-
sured MET calculation. In this study the subjects had, 
on average, a value lower than 3.5 kcal·kg−1·min−1, espe-
cially women. This is another reason that justifies the 
use of specific calibration equations.11,12 The use of 
MET score based on the individual resting energy 
expenditure could lead to a different number of counts 
necessary to achieve a certain PA intensity. In the sample 
of this study it was obtained a VO2 resting value lower 
than 3.5 ml·kg−1·min−1. This fact had the consequence of 
decreasing the number of counts necessary to achieve a 
certain PA intensity in contrast with the MET score 
based on 3.5 ml·kg−1·min−1.
In the current study a high validity value (r2 = .75) 
was obtained. The predicted energy expenditure found 
by Freedson et al18 in adults, while walking at different 
speeds on a treadmill, from Actigraph counts and BMI, 
obtained an r2 = .82. In a calibration study of Biotrainer 
and Actitrac activity monitors, Welk et al,34 found a high 
validation coefficients (r2 = .88 to 0.94) in walking/jog-
ging on a treadmill. In another study, Nilsson et al37 
examined the effect of monitor placement (hip vs. back) 
and activity setting (treadmill vs. track) on the output of 
Actigraph and obtained high validation coefficients (r2 
Table 3 Threshold Counts for Sedentary, Light, Moderate, Vigorous, and Very Vigorous Levels of 
Physical Activity
Physical activity level MET Counts Sensitivity Specificity Area under the curve
Sedentary <1.5
Light 1.5 200 91.55 94.00 0.98
Moderate 3 1240 100 76.81 0.95
Vigorous 6 2400 100 69.74 0.94
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 20. Tibb AS, Ennezat PV, Chen JA, Haider A, Gundewar S, 
Cotarlan V, Aggarwal VS, Talreja A, Le Jemtel TH. Dia-
explained by the particular characteristics of the sample 
used, namely the older age, the obesity/overweight and 
the disease conditions. Actually, it was found20 that peak 
VO2 was substantially lower in diabetic than in nondia-
betic patients with 61 years of age. The combination of 
these factors may, therefore, lead to an inferior level of 
physical fitness. With smaller levels of physical fitness 
the subjects of the sample of this study reach a certain 
PA intensity with lower speed of walking than the 
younger and fitter subjects, and as a consequence, a 
inferior number of counts. For instance Freedson et al18 
for 4.8 km·h−1 walking speed found 3.7 ± 0.3 METs, 
and Hendelman et al19 for a similar speed (4.75 km·h−1) 
found a similar PA intensity (3.33 ± 0.76 METs). In the 
current study for comparable walking speed (5 km·h−1) 
a PA intensity of 5.8 ± 1.3 and 7.0 ± 2.4 METs for 
sample 1 and sample 2 was obtained, respectively. The 
overweight/obesity by itself is a condition that can influ-
ence the number of counts in an ambulatory activity, 
since for the same activity a person with more weight 
spends more energy than others with less weight. The 
other reason is the use of MET score based on the indi-
vidual resting energy expenditure. In fact, as it was 
stated above, for the same PA intensity, there will be less 
counts with the MET score based on the individual rest-
ing energy expenditure than with the MET score based 
on 3.5 mL/kg/min, because the sample of this study had 
lower resting VO2 than 3.5 ml·kg−1·min−1.
The limitation of this study lays in the fact that only 
run and walk were used as mode of PA. Actually, the 
number of counts measured might depend on the mode 
of PA.16 This fact limits the use of the obtained regres-
sion equation and the thresholds counts of PA levels to 
ambulatory PA.
In conclusion, the validation of the Actigraph 
against MET scores and its calibration for sedentary, 
light, moderate, and vigorous ambulatory PA thresholds 
counts certifies this monitor as a valid, useful device for 
the assessment of the amount of time spent in several PA 
intensities in middle-aged to old obese and DM2 adult 
patients.
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